Inventor
DIEBOLD R BRUCE
US24 patents
⚠️ This page may combine multiple inventors who share the name “DIEBOLD R BRUCE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FORMA THERAPEUTICS INC
17 patentsUS10550098B2Feb 4, 2020
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC17 citations94
US10414752B2Sep 17, 2019
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC19 citations94
US10005734B2Jun 26, 2018
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC25 citations94
US9834539B2Dec 5, 2017
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC28 citations94
US9815817B2Nov 14, 2017
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC24 citations94
US9771349B2Sep 26, 2017
Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC27 citations94
US9624175B2Apr 18, 2017
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC25 citations94
US9624216B2Apr 18, 2017
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC26 citations94
US10377760B2Aug 13, 2019
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC17 citations93
US9902728B2Feb 27, 2018
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC24 citations93
US11498913B2Nov 15, 2022
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC4 citations84
US10889567B2Jan 12, 2021
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC5 citations84
US10550099B2Feb 4, 2020
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC4 citations84
US10807976B2Oct 20, 2020
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC2 citations73
US10577329B2Mar 3, 2020
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC4 citations73
US10407419B2Sep 10, 2019
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC5 citations73
US12275715B2Apr 15, 2025
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA THERAPEUTICS INC0 citations63
FORMA TM2 INC
4 patentsUS10280150B2May 7, 2019
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
FORMA TM2 INC19 citations93
US10266495B2Apr 23, 2019
Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA TM2 INC19 citations93
US10253015B2Apr 9, 2019
Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA TM2 INC20 citations93
US10294206B2May 21, 2019
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
FORMA TM2 INC7 citations83